US Broker Ratings

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a 39% Potential Upside in the Medical Instruments Sector

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is capturing investor attention with its significant growth potential. Headquartered..

CVS Health Corporation (CVS) Stock Analysis: Evaluating an 18% Potential Upside Amid Strong Buy Ratings

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, continues to captivate investors with its expansive reach and robust market presence. With a current market capitalization of $101.72..

Waystar Holding Corp. (WAY) Stock Analysis: Unlocking a 54% Potential Upside

For investors keen on exploring opportunities in the healthcare sector, Waystar Holding Corp. (NASDAQ: WAY) presents a compelling case with a striking potential upside of 54.13%. Headquartered in Lehi, Utah,..

Illumina, Inc. (ILMN) Stock Analysis: Can This Genomics Leader Defy Its Potential Downside?

Illumina, Inc. (NASDAQ: ILMN) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in San Diego, California, Illumina’s core business revolves around providing..

Bruker Corporation (BRKR) Stock Report: Assessing the 8.83% Potential Upside for Investors

Bruker Corporation (NASDAQ: BRKR) is a key player in the healthcare sector, specifically within the medical devices industry, offering a rich portfolio of scientific instruments and analytical solutions. Headquartered in..

Corcept Therapeutics (CORT) Stock Analysis: A Biotech Innovator with 138% Potential Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT) is making waves in the biotechnology sector, presenting a compelling opportunity for investors with a notable potential upside of 138.22%. With its innovative approach to..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Assessing the 14% Potential Upside in the Medical Devices Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a distinguished player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $8.23 billion, Bio-Rad is a..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare Market with 7.84% Potential Upside

Teleflex Incorporated (NYSE: TFX) stands at the crossroads of innovation and opportunity within the healthcare sector, with its latest stock analysis revealing a potential upside of 7.84%. As a key..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Healthcare Distribution with Steady Growth

As an investor in the healthcare sector, understanding the dynamics of companies like Henry Schein, Inc. (NASDAQ: HSIC) is crucial for building a diversified portfolio. With a market capitalization of..

Encompass Health Corporation (EHC) Stock Analysis: Unpacking a 31.93% Potential Upside

Encompass Health Corporation (NYSE: EHC) has captured the attention of investors with its robust growth prospects and substantial potential upside. Operating in the healthcare sector, EHC specializes in providing post-acute..

Roivant Sciences Ltd. (ROIV) Stock Analysis: A 19% Potential Upside in the Biotech Innovator

Roivant Sciences Ltd. (NASDAQ: ROIV), a London-based clinical-stage biopharmaceutical company, is increasingly capturing investor attention with its innovative approach to drug discovery and development. The company, which has carved a..

Revvity, Inc. (RVTY) Stock Analysis: Potential 16.53% Upside in Healthcare Diagnostics

Revvity, Inc. (NYSE: RVTY), a key player in the healthcare sector, specifically within the diagnostics and research industry, presents a compelling opportunity for investors seeking to capitalize on its position..

Globus Medical, Inc. (GMED) Stock Analysis: A Promising 13% Upside in the Medical Device Sector

Globus Medical, Inc. (NYSE: GMED) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $11.79 billion, the company has..

Charles River Laboratories (CRL) Stock Analysis: Navigating a Challenging Landscape with Innovation and Strategic Alliances

Charles River Laboratories International, Inc. (NYSE: CRL) remains a pivotal player in the healthcare sector, particularly within diagnostics and research. With a market capitalization of $9.96 billion, Charles River is..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unpacking a Promising 10.64% Upside in the Biotech Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a burgeoning player in the healthcare sector, is making waves in the biotechnology industry. With a market capitalization of $15.08 billion, the company stands out..

Quest Diagnostics (DGX) Stock Analysis: Potential 13.97% Upside Captures Investor Attention

Quest Diagnostics Incorporated (NYSE: DGX), a significant player in the healthcare sector, stands out with a market capitalization of $19.43 billion. This diagnostic and research titan, headquartered in Secaucus, New..

Exact Sciences Corporation (EXAS) Stock Analysis: Unveiling Growth Potential in Cancer Diagnostics

Exact Sciences Corporation (NASDAQ: EXAS), a pivotal player in the healthcare sector, is making waves in the diagnostics and research industry with its innovative cancer screening solutions. With a robust..

Repligen Corporation (RGEN): Investor Outlook with a 15% Upside Potential in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN), a prominent player in the life sciences sector, is capturing investor attention with its promising growth trajectory and a potential upside of 15.13%. Based in Waltham,..

Universal Health Services, Inc. (UHS) Stock Analysis: Potential Upside Amid Solid Performance Metrics

Universal Health Services, Inc. (NYSE: UHS), a prominent player in the healthcare sector, operates an extensive network of acute care and behavioral health facilities across the United States. With a..

Abbott Laboratories (ABT) Stock Analysis: Exploring the 16.52% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and promising growth metrics. As a leader in the medical..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds